| Company Name: |
Cato Research Chemicals Inc.
|
| Tel: |
020-81215950 4000-868-328 |
| Email: |
customer@uwalab.com |
| Products Intro: |
Product Name:Daclatasvir Impurity 7
CAS:1447744-93-5
Purity:95%（HPLC） Package:10mg；25mg；50mg；100mg
|
| Company Name: |
Wuxi Minglu Medicine technology Co.,Ltd.
|
| Tel: |
0510-88726693 |
| Email: |
3204601684@qq.com |
| Products Intro: |
Product Name:Daclatasvir Impurity 7
CAS:1447744-93-5
Purity:0.98 Package:10mg、25mg、50mg、100mg
|
| Company Name: |
Shenzhen Roark Pharma-Tec Co., Ltd.
|
| Tel: |
13128912434 |
| Email: |
2880126944@qq.com |
| Products Intro: |
Product Name:Daclatasvir Impurity 7
CAS:11447744-93-5
Purity:99% HPLC Package:10MG;25MG;50MG;100MG
|
| Company Name: |
Pharmaffiliates Analytics and Synthetics P. Ltd
|
| Tel: |
+91-172-5066494 |
| Email: |
mktg@pharmaffiliates.com |
| Products Intro: |
Product Name:1,1''-((2S,2''S)-([1,1''-biphenyl]-4,4''-diylbis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(ethan-1-one)
CAS:1447744-93-5
|
|
| | Daclatasvir Impurity 7 Basic information |
| Product Name: | Daclatasvir Impurity 7 | | Synonyms: | Daclatasvir Impurity 7;1,1''-((2S,2''S)-([1,1''-biphenyl]-4,4''-diylbis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(ethan-1-one);1,1'-(2S,2'S)-2,2'-(5,5'-([1,1'-Biphenyl]-4,4'-diyl)bis[1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))diethanone;Ethanone, 1,1'-[[1,1'-biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl]]bis-;Daclatasvir impurity 12/1,1’-(2S,2’S)-2,2’-(5,5’-([1,1’-Biphenyl]-4,4’-diyl)bis[1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))diethanone | | CAS: | 1447744-93-5 | | MF: | C30H32N6O2 | | MW: | 508.61 | | EINECS: | | | Product Categories: | | | Mol File: | 1447744-93-5.mol |  |
| | Daclatasvir Impurity 7 Chemical Properties |
| Boiling point | 960.3±65.0 °C(Predicted) | | density | 1.271±0.06 g/cm3(Predicted) | | pka | 12.83±0.10(Predicted) |
| | Daclatasvir Impurity 7 Usage And Synthesis |
| Uses | 1,1''-(2S,2''S)-2,2''-(5,5''-([1,1''-Biphenyl]-4,4''-diyl)bis[1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))diethanone is derived from 5,5''-[1,1''-Biphenyl]-4,4''-diylbis[2-(2S)-2-pyrrolidinyl-1H-imidazole] Hydrochloride (B397775), which is the derivative of Daclatasvir (D101500) that inhibits the HCV protein NS5A, and thus can be used a drug candidate for the treatment of hepatitis C (HCV). |
| | Daclatasvir Impurity 7 Preparation Products And Raw materials |
|